Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-04 04:18:05 - browse：3653

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How to save health care price transparency rules

explore

WSS

WATCH: Why do bright lights make us see spots?

Food makers to regulators: Ultra

Popular nasal decongestant doesn't actually relieve congestion

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

EPA limits use of carcinogenic gas for sterilizing medical devices

WATCH: Why do bright lights make us see spots?

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Walensky prepares to leave CDC — and Congress — behind

Why depression after traumatic brain injury is distinct

Walensky prepares to leave CDC — and Congress — behind

Hospitals consider fixing cancer drug shortages on their own

State Dept. review finds Biden bears some blame for Afghanistan failures

Hospitals consider fixing cancer drug shortages on their own

State Dept. review finds Biden bears some blame for Afghanistan failures

What to make of Biden’s latest efforts on cancer research

Apple is now the first public company to be valued at $3 trillion

Acelyrin, a rare IPO success, stumbles in its first big test

focus

As AI in medicine takes off, can 'human in the loop' prevent harm?

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Generate Biomedicines machine learning biotech raises $273M

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

UCLA team creates talking throat patch for voice disorders

John Green on his newest strategy for fighting tuberculosis

focus

hotspot

explore

focus